Li ZY - Search Results

1

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments.

Li ZY, Wu G, Qiu C, Zhou ZJ, Wang YP, Song GH, Xiao C, Zhang X, Deng GL, Wang RT, Yang YL, Wang XL. Li ZY, et al. World J Gastroenterol. 2022 Jul 7;28(25):2937-2954. doi: 10.3748/wjg.v28.i25.2937. World J Gastroenterol. 2022. PMID: 35978872 Free PMC article.

2

The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms.

Li Z, Shen W, Wu G, Qin C, Zhang Y, Wang Y, Song G, Xiao C, Zhang X, Deng G, Wang R, Wang X. Li Z, et al. FEBS Open Bio. 2021 Jul;11(7):1893-1906. doi: 10.1002/2211-5463.13146. Epub 2021 May 27. FEBS Open Bio. 2021. PMID: 33728819 Free PMC article.

3

Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.

Qiu C, Li Z, Cao W, Cai X, Ye L, Zhang C, Ma Y, Wang X, Yang Y. Qiu C, et al. Biosci Rep. 2021 Sep 30;41(9):BSR20203978. doi: 10.1042/BSR20203978. Biosci Rep. 2021. PMID: 34435618 Free PMC article.

4

Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer.

Gu P, Zhang L, Wang R, Ding W, Wang W, Liu Y, Wang W, Li Z, Yan B, Sun X. Gu P, et al. Front Cell Dev Biol. 2021 Dec 16;9:796729. doi: 10.3389/fcell.2021.796729. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34977036 Free PMC article.

5

Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma.

Li Z, Song G, Guo D, Zhou Z, Qiu C, Xiao C, Wang X, Wang Y. Li Z, et al. J Cancer. 2022 Jan 1;13(2):610-622. doi: 10.7150/jca.53841. eCollection 2022. J Cancer. 2022. PMID: 35069907 Free PMC article.

6

Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.

Shen L, Gu P, Qiu C, Ding WT, Zhang L, Cao WY, Li ZY, Yan B, Sun X. Shen L, et al. Among authors: li zy. Ann Hepatol. 2022 May-Jun;27(3):100680. doi: 10.1016/j.aohep.2022.100680. Epub 2022 Jan 30. Ann Hepatol. 2022. PMID: 35108614 Free article.

7

Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.

Li Z, Wang R, Qiu C, Cao C, Zhang J, Ge J, Shi Y. Li Z, et al. Front Immunol. 2022 Mar 22;13:834606. doi: 10.3389/fimmu.2022.834606. eCollection 2022. Front Immunol. 2022. PMID: 35392073 Free PMC article.

8

Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8⁺- T cell-mediated anti-tumor immunity.

Xin X, Li Z, Yan X, Liu T, Li Z, Chen Z, Yan X, Zeng F, Hou L, Zhang J. Xin X, et al. Theranostics. 2024 Sep 9;14(15):5853-5868. doi: 10.7150/thno.97276. eCollection 2024. Theranostics. 2024. PMID: 39346534 Free PMC article.

9

WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma.

Li Y, Cheng Q, Gao J, Chen Z, Guo J, Li Z, Tian L, Zhang C, Li Y, Zheng J, Li Z, Zhu J. Li Y, et al. Cell Death Discov. 2022 Mar 9;8(1):107. doi: 10.1038/s41420-022-00882-0. Cell Death Discov. 2022. PMID: 35264565 Free PMC article.

10

Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes.

Chen Z, Gao J, Li Z, Ma D, Wang Y, Cheng Q, Zhu J, Li Z. Chen Z, et al. Liver Int. 2024 Sep;44(9):2477-2493. doi: 10.1111/liv.16015. Epub 2024 Jun 25. Liver Int. 2024. PMID: 38924592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,090 results

Search Page

Filters